Written by Laura Dyrda | Tuesday, 10 May 2016
TranS1 continues to build around its core product, AxiaLIF, acquired from Baxano. The technology is designed for surgeons to perform L5-S1 spinal fusions without removing the facet joints and destabilizing the spine.
AxiaLIF technology approaches the spine through the pre-sacral space. Unlike the lateral approach, surgeons do not need to dissect the psoas muscle. It is also different from the transforaminal approach, as surgeons do not need to remove the facet joint during the approach and thereby risk lingering instability. Lastly, it also differs from the anterior approach (ALIF),as the surgeon does not need to filet open the abdomen.
“These other approaches to the spine cause serious damage to the tissues that surgeons are required to traverse to access the spine,” says Jeffrey Schell, CEO of TranS1. “Our mission is to minimize the collateral damage that the approach causes. The AxiaLIF procedure minimizes the need to dissect through muscles with an incision approximately 2 cm long. The procedure can be performed on an outpatient basis and can avoid the major complications often associated with spine surgery, including nerve damage.”
